APOL1 and Alport syndrome: Of these, variants in COL4A3/4/5 (associated with Alport syndrome spectrum) comprised 31.8% of positive cases, and APOL1 high-risk genotypes comprised 45.5% (Figure 1C, Table 2, and Supplemental Table 9).